Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

A Systematic Review on the Effect of HIV Infection on the Pharmacokinetics of First-Line Tuberculosis Drugs

Research output: Contribution to journalReviewResearchpeer-review

  1. Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Clinical Pharmacokinetics and Pharmacodynamics of Albiglutide

    Research output: Contribution to journalReviewResearchpeer-review

  3. Pharmacokinetics of Melatonin: The Missing Link in Clinical Efficacy?

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Pharmacology and optimization of thiopurines and metothrexate in inflammatory bowel disease

    Research output: Contribution to journalReviewResearchpeer-review

  5. Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Patterns of cerebral tissue oxygen tension and cytoplasmic redox state in bacterial meningitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Serum creatinine and estimated glomerular filtration rates in HIV positive and negative adults in Ethiopia

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Mycobacterium brisbanense lung infection facilitated by steroid induced adrenal insufficiency

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Alper Daskapan
  • Lusiana R Idrus
  • Maarten J Postma
  • Bob Wilffert
  • Jos G W Kosterink
  • Ymkje Stienstra
  • Daniel J Touw
  • Aase B Andersen
  • Adrie Bekker
  • Paolo Denti
  • Agibothu K Hemanth Kumar
  • Kidola Jeremiah
  • Awewura Kwara
  • Helen McIlleron
  • Graeme Meintjes
  • Joep J van Oosterhout
  • Geetha Ramachandran
  • Neesha Rockwood
  • Robert J Wilkinson
  • Tjip S van der Werf
  • Jan-Willem C Alffenaar
View graph of relations

INTRODUCTION: Contrasting findings have been published regarding the effect of human immunodeficiency virus (HIV) on tuberculosis (TB) drug pharmacokinetics (PK).

OBJECTIVES: The aim of this systematic review was to investigate the effect of HIV infection on the PK of the first-line TB drugs (FLDs) rifampicin, isoniazid, pyrazinamide and ethambutol by assessing all published literature.

METHODS: Searches were performed in MEDLINE (through PubMed) and EMBASE to find original studies evaluating the effect of HIV infection on the PK of FLDs. The included studies were assessed for bias and clinical relevance. PK data were extracted to provide insight into the difference of FLD PK between HIV-positive and HIV-negative TB patients. This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement and its protocol was registered at PROSPERO (registration number CRD42017067250).

RESULTS: Overall, 27 studies were eligible for inclusion. The available studies provide a heterogeneous dataset from which consistent results could not be obtained. In both HIV-positive and HIV-negative TB groups, rifampicin (13 of 15) and ethambutol (4 of 8) peak concentration (Cmax) often did not achieve the minimum reference values. More than half of the studies (11 of 20) that included both HIV-positive and HIV-negative TB groups showed statistically significantly altered FLD area under the concentration-time curve and/or Cmax for at least one FLD.

CONCLUSIONS: HIV infection may be one of several factors that reduce FLD exposure. We could not make general recommendations with respect to the role of dosing. There is a need for consistent and homogeneous studies to be conducted.

Original languageEnglish
JournalClinical Pharmacokinetics
Volume58
Issue number6
Pages (from-to)747-766
Number of pages20
ISSN0312-5963
DOIs
Publication statusPublished - 1 Jun 2019

ID: 56393325